Prothena Corp Q1 2024 GAAP EPS $(1.34) Misses $(1.20) Estimate, Sales $900.00K Miss $2.17M Estimate
Portfolio Pulse from Benzinga Newsdesk
Prothena Corp (NASDAQ:PRTA) reported Q1 2024 GAAP EPS of $(1.34), missing the $(1.20) estimate, with sales of $900.00K also missing the $2.17M estimate, a 58.51% decrease from the same period last year.
May 08, 2024 | 8:22 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Prothena Corp reported a significant miss in both EPS and sales for Q1 2024, with a notable year-over-year decrease in sales.
Missing both EPS and sales estimates significantly, especially with such a large year-over-year decrease in sales, is likely to negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100